Page last updated: 2024-11-13

tropaeolin oo

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tropaeolin OO: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23668839
SCHEMBL ID218141
MeSH IDM0047690

Synonyms (48)

Synonym
benzenesulfonic acid, 4-[[4-(phenylamino)phenyl]azo]-, monosodium salt
tertracid orange iv
orange n
tropaeolin oo
solar orange iv
diphenylamine orange
orange iv
sodium p-diphenylamino-azobenzenesulfonate
hispacid orange iv
orange 4 lake
tropeolin oo
554-73-4
acid yellow d
nsc-10456
orange gs
c.i. 13080
c.i. acid orange 5, monosodium salt
c.i. acid orange 5
A0576
acid orange 5
AKOS005111000
FT-0682673
einecs 209-071-4
sodium 4-((4-(anilino)phenyl)azo)benzenesulphonate
benzenesulfonic acid, p-((p-anilinophenyl)azo)-, sodium salt
unii-vr8q3r288w
benzenesulfonic acid, p-((p-anilinophenyl)azo)-, monosodium salt
vr8q3r288w ,
nsc 10456
benzenesulfonic acid, 4-(2-(4-(phenylamino)phenyl)diazenyl)-, sodium salt (1:1)
benzenesulfonic acid, 4-((4-(phenylamino)phenyl)azo)-, monosodium salt
AKOS015903188
4-(2-(4-(phenylamino)phenyl)diazenyl)benzenesulfonic acid sodium salt (1:1)
tropaeolin oo [mi]
ci-13080
SCHEMBL218141
sodium 4-[(4-anilinophenyl)diazenyl]-benzenesulfonate
DTXSID8060294
sodium 4-[(4-anilinophenyl)diazenyl]benzene-1-sulfonate
orangeiv
AKOS025116979
4-(4-anilinophenylazo)benzenesulfonic acid sodium salt
mfcd00038130
sodium (e)-4-((4-(phenylamino)phenyl)diazenyl)benzenesulfonate
Q6270611
sodium;4-[(4-anilinophenyl)diazenyl]benzenesulfonate
A870183
4-[(4-anilinophenyl)azo]benzenesulfonic acid sodium salt

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The proposed methods have been applied successfully for the analysis of the drug in its dosage forms."( Extractive spectrophotometric methods for determination of zolmitriptan in tablets.
Aydogmus, Z; Inanli, I,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.39 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index20.59 (26.88)
Search Engine Supply Index1.50 (0.95)

This Compound (28.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]